alanine has been researched along with apilimod in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albrecht, R; Benner, C; Burgstaller-Muehlbacher, S; Cao, J; Chan, JF; Chanda, SK; Chang, MW; Chapman, ME; Chatterjee, AK; Cheng, K; Choi, A; De Jesus, PD; Dejosez, M; García-Sastre, A; Glynne, RJ; Herbert, KM; Hull, MV; Johnson, JR; Lendy, EK; Liu, WC; Martin-Sancho, L; Martinez-Sobrido, L; Matsunaga, N; Mesecar, AD; Miorin, L; Nguyen, C; Nguyen, TH; Pache, L; Poon, VK; Pu, Y; Rathnasinghe, R; Riva, L; Rubanov, A; Ruppin, E; Schotsaert, M; Schultz, PG; Sit, KY; Su, AI; Sun, R; Teriete, P; White, KM; Yin, X; Yuan, S; Yuen, KY; Zwaka, TP | 1 |
1 other study(ies) available for alanine and apilimod
| Article | Year |
|---|---|
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.
Topics: Adenosine Monophosphate; Alanine; Alveolar Epithelial Cells; Antiviral Agents; Betacoronavirus; Cell Line; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Repositioning; Drug Synergism; Gene Expression Regulation; Humans; Hydrazones; Induced Pluripotent Stem Cells; Models, Biological; Morpholines; Pandemics; Pneumonia, Viral; Pyrimidines; Reproducibility of Results; SARS-CoV-2; Small Molecule Libraries; Triazines; Virus Internalization; Virus Replication | 2020 |